Intravenous Dexamethasone for Prolonged Duration of Axillary Nerve Blockade

Area of Science:

• Anesthesiology
• Pharmacology
• Orthopedic Surgery

Background:

• Effective pain management is crucial for patients undergoing orthopedic surgery.
• Regional anesthesia, including peripheral nerve blocks, is a preferred method for intraoperative and postoperative pain control.
• Opioid use for postoperative pain is associated with significant side effects.

Purpose of the Study:

• To evaluate the efficacy of intravenous dexamethasone in prolonging the analgesic effects of axillary nerve blocks for orthopedic surgery.
• To assess the impact of dexamethasone on postoperative opioid requirements.

Main Methods:

• A case study involving a 61-year-old woman undergoing open reduction and internal fixation of bilateral distal radius fractures.
• General anesthesia combined with bilateral axillary nerve blocks using bupivacaine.
• A single 8-mg intravenous dose of dexamethasone administered to prolong analgesia.

Main Results:

• The patient experienced significantly reduced postoperative opioid consumption, requiring only one dose of morphine during hospitalization.
• The combination of intravenous dexamethasone and bupivacaine in axillary nerve blocks demonstrated prolonged analgesic effects.
• This case supports existing research on the benefits of intravenous dexamethasone for extended pain relief.

Conclusions:

• Intravenous administration of dexamethasone, 8 mg, is an effective adjunct to peripheral nerve blocks for managing pain after orthopedic surgery.
• This method offers a viable strategy to minimize opioid use in the postoperative period.
• Further research supports the use of intravenous dexamethasone for prolonged analgesia, as perineural administration lacks FDA approval.